DNOW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DNOW is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some near-term technical stability, but the recent 19% drop tied to ERP issues and the ongoing securities investigations create a weak risk-reward setup. With no Intellectia buy signals and only modest upside indicated by analysts, the better call is to hold off rather than buy immediately.
Price is 13.56, slightly above the prior close, with short-term momentum improved but still weak overall. MACD histogram is barely positive at 0.00212 and contracting, which suggests fading momentum rather than a strong breakout. RSI_6 at 58.94 is neutral to mildly positive, not overbought. Moving averages are converging, signaling a consolidating trend. Key levels: pivot 13.259, resistance at 13.708 and 13.985, support at 12.81 and 12.533. The stock is trading near pivot, so the chart does not yet confirm a high-confidence trend reversal.
["Stifel still maintains a Buy rating and sees the ERP issues as ultimately transitory.", "The stock closed higher on the day, and short-term technicals are no longer deeply oversold.", "Options positioning is mildly bullish, with calls still favored over puts.", "Potential stabilization around current support near 12.81 could help near-term price recovery."]
["Shares fell 19% after FY 2025 results due to ERP issues, which is the main overhang.", "Hagens Berman and Rosen Law Firm investigations raise litigation and sentiment risk.", "Hedge funds are selling heavily, with selling up 4965.22% over the last quarter.", "No insider accumulation is visible; insiders are neutral.", "AI Stock Picker has no signal and SwingMax has no recent signal, removing proprietary bullish support."]
No detailed quarter financials were provided due to a data error, so a full financial assessment is limited. Based on the news, the latest fiscal year 2025 results were negatively received because ERP issues affected performance and investor confidence. There is no clear evidence in the provided data of accelerating growth in the latest quarter season, and the market reaction suggests operational execution concerns are currently outweighing business progress.
Analyst sentiment remains cautiously positive but has weakened. Stifel lowered its price target to $16 from $18 while keeping a Buy rating, implying upside from the current price but with reduced conviction. The note specifically cites increased risk from lingering ERP issues while calling them transitory. Overall, Wall Street pros appear split: the bulls still see value and eventual recovery, while the bears are focused on execution risk, litigation concerns, and the recent sharp selloff.
